293 related articles for article (PubMed ID: 35284118)
1. Development and verification of a microsatellite instability-related risk signature for predicting survival and therapy effectiveness in gastric cancer.
Zhang T; Yu S; Zhao S
J Gastrointest Oncol; 2022 Feb; 13(1):84-101. PubMed ID: 35284118
[TBL] [Abstract][Full Text] [Related]
2. Immune-related gene signature predicts overall survival of gastric cancer patients with varying microsatellite instability status.
Tian R; Hu J; Ma X; Liang L; Guo S
Aging (Albany NY); 2020 Dec; 13(2):2418-2435. PubMed ID: 33316777
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
[TBL] [Abstract][Full Text] [Related]
4. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
Hu B; Meng Y; Qu C; Wang BY; Xiu DR
Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
[TBL] [Abstract][Full Text] [Related]
5. Construction of a miRNA Signature Using Support Vector Machine to Identify Microsatellite Instability Status and Prognosis in Gastric Cancer.
Wang YN; Wei YN; Fan XY; Xu F; Dong ZY; Cheng SJ; Zhang JK
J Oncol; 2022; 2022():6586354. PubMed ID: 35466315
[TBL] [Abstract][Full Text] [Related]
6. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
7. Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer.
Zhang M; Cao C; Li X; Gu Q; Xu Y; Zhu Z; Xu D; Wei S; Chen H; Yang Y; Gao H; Yu L; Li J
Cancer Med; 2023 Jan; 12(2):2075-2088. PubMed ID: 35789544
[TBL] [Abstract][Full Text] [Related]
8. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma.
Liu X; Fang X; Lu L; Liu G
Front Genet; 2022; 13():996625. PubMed ID: 36568396
[No Abstract] [Full Text] [Related]
10. A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study.
Zhan PC; Yang S; Liu X; Zhang YY; Wang R; Wang JX; Qiu QY; Gao Y; Lv DB; Li LM; Luo CL; Hu ZW; Li Z; Lyu PJ; Liang P; Gao JB
BMC Cancer; 2024 Apr; 24(1):404. PubMed ID: 38561648
[TBL] [Abstract][Full Text] [Related]
11. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
12. Identification of an Immune-Related Signature Predicting Survival Risk and Immune Microenvironment in Gastric Cancer.
Dai S; Liu T; Liu XQ; Li XY; Xu K; Ren T; Luo F
Front Cell Dev Biol; 2021; 9():687473. PubMed ID: 34805135
[No Abstract] [Full Text] [Related]
13. Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer.
Zeng Z; Xie D; Gong J
PeerJ; 2020; 8():e9624. PubMed ID: 32821544
[TBL] [Abstract][Full Text] [Related]
14. HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer.
Jiang R; Wang J; Liang J; Lin D; Mao Q; Cheng S; Huang S; Tong S; Lyu Y; Wei R; Lian Q; Chen H
Front Pharmacol; 2022; 13():1096055. PubMed ID: 36712672
[No Abstract] [Full Text] [Related]
15. The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer.
Zhao Z; Mak TK; Shi Y; Huang H; Huo M; Zhang C
Front Immunol; 2023; 14():1117255. PubMed ID: 37457685
[TBL] [Abstract][Full Text] [Related]
16. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer.
Liu ZY; Xin L
Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804
[TBL] [Abstract][Full Text] [Related]
17. Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer.
Song S; Liu S; Wei Z; Jin X; Mao D; He Y; Li B; Zhang C
Front Cell Dev Biol; 2021; 9():726716. PubMed ID: 34621744
[No Abstract] [Full Text] [Related]
18. Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden.
Chen Z; Cheng G
Recent Pat Anticancer Drug Discov; 2023 Sep; ():. PubMed ID: 37691229
[TBL] [Abstract][Full Text] [Related]
19. Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer.
Zhang F; Li X; Chen H; Guo J; Xiong Z; Yin S; Jin L; Chen X; Luo D; Tang H; Mao C; Lian L
Front Med (Lausanne); 2022; 9():836892. PubMed ID: 35211490
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite Instability-Related
Zhao L; Zhang J; Qu X; Yang Y; Gong Z; Yang Y; Wu Z; Guo W
Onco Targets Ther; 2020; 13():3809-3821. PubMed ID: 32440149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
